pathway,nums,percent,pvalue,,
Ribosome,75,75,0,,
"Ribosome, eukaryotes",59,89.39,0,,
Spliceosome,97,95.1,0,,
Coronavirus disease - COVID-19,94,80.34,0,,
DNA replication,33,100,0,,
Base excision repair,27,81.82,0,,
Ribosome biogenesis in eukaryotes,48,85.71,0,,
Nuclear pore complex,22,73.33,0,,
Mismatch repair,22,100,0,,
mRNA surveillance pathway,57,85.07,0,,
RNA degradation,26,56.52,0,,
Nucleocytoplasmic transport,74,89.16,0,,
Homologous recombination,28,90.32,0,,
"Spliceosome, U4/U6.U5 tri-snRNP",17,80.95,0,,
"Spliceosome, U2-snRNP",17,89.47,0,,
Polycomb repressive complex,58,92.06,0,,
Cell cycle,127,97.69,0,,
"Spliceosome, 35S U5-snRNP",23,88.46,0,,
RNA transport,107,93.04,0.0001,,
RNA polymerase,12,54.55,0.0001,,
BRCA1-associated genome surveillance complex (BASC),15,100,0.0001,,
Herpes simplex infection,83,88.3,0.0001,,
Nucleotide excision repair,35,83.33,0.0002,,
"RNA polymerase II, eukaryotes",6,100,0.0003,,
"Spliceosome, U1-snRNP",8,88.89,0.0005,,
Sm core complex,7,100,0.0008,,
MCM complex,6,100,0.0026,,
Fanconi anemia pathway,24,75,0.0036,,
"RNA polymerase I, eukaryotes",7,100,0.0035,,
Exon junction complex (EJC),13,81.25,0.0044,,
RF-C complex,5,100,0.0069,,
Oocyte meiosis,62,79.49,0.0127,,
"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",6,100,0.0158,,
FA core complex,6,100,0.0185,,
Cell cycle - G2/M transition,7,100,0.032,,
DNA damage-induced cell cycle checkpoints,7,100,0.0377,,
Pyrimidine metabolism,61,85.92,0.0382,,
"RNA polymerase III, eukaryotes",6,54.55,0.0451,,
"Exosome, eukaryotes",6,100,0.0446,,
Non-homologous end-joining,6,100,0.0453,,
Basal transcription factors,32,82.05,0.0485,,
Antifolate resistance,11,73.33,0.0482,,
Glycolysis / Gluconeogenesis,14,45.16,0.0504,,
Systemic lupus erythematosus,6,50,0.0497,,
Amyotrophic lateral sclerosis,150,77.72,0.0597,,
Nitrogen metabolism,5,83.33,0.0861,,
Shelterin complex,5,100,0.1148,,
Purine metabolism,83,86.46,0.1156,,
One carbon pool by folate,10,76.92,0.1147,,
"Spliceosome, Prp19/CDC5L complex",8,100,0.1129,,
"Citrate cycle (TCA cycle, Krebs cycle)",17,100,0.1223,,
Citrate cycle (TCA cycle),21,100,0.1329,,
"Citrate cycle, first carbon oxidation, oxaloacetate => 2-oxoglutarate",6,100,0.1395,,
BMP signaling,7,63.64,0.188,,
Viral life cycle - HIV-1,23,67.65,0.1897,,
Progesterone-mediated oocyte maturation,55,82.09,0.224,,
Cytochrome bc1 complex,7,100,0.2559,,
"NADH dehydrogenase (ubiquinone) Fe-S protein/flavoprotein complex, mitochondria",8,100,0.2839,,
Tyrosine metabolism,17,100,0.2825,,
Origin recognition complex,6,100,0.2995,,
TREX complex,7,87.5,0.3197,,
"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate",11,100,0.3185,,
Transcriptional misregulation in cancer,77,83.7,0.3136,,
Phenylalanine metabolism,10,100,0.359,,
Chemical carcinogenesis - receptor activation,85,83.33,0.3666,,
Thyroid cancer,11,52.38,0.3788,,
Breast cancer,49,68.06,0.3805,,
Cell cycle - G1/S transition,10,83.33,0.4137,,
"Glycolysis, core module involving three-carbon compounds",6,100,0.4239,,
Glyoxylate and dicarboxylate metabolism,20,100,0.4241,,
Bladder cancer,13,54.17,0.43,,
Drug metabolism - other enzymes,26,65,0.4374,,
Legionellosis,12,50,0.4385,,
Proximal tubule bicarbonate reclamation,8,57.14,0.4349,,
"Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate",11,100,0.4388,,
Chemical carcinogenesis - reactive oxygen species,64,52.46,0.4679,,
Platinum drug resistance,40,68.97,0.4653,,
Glutathione metabolism,24,60,0.4833,,
Arginine and proline metabolism,6,22.22,0.4934,,
Parkinson disease,96,67.61,0.5258,,
Folate biosynthesis,11,100,0.5288,,
"Proteasome, 20S core particle",9,100,0.5449,,
Phosphatidylinositol signaling system,20,35.09,0.5576,,
Triacylglycerol biosynthesis,9,100,0.5855,,
Nucleotide metabolism,32,68.09,0.5819,,
IL-17 signaling pathway,12,30,0.6458,,
Selenocompound metabolism,11,100,0.6404,,
BER complex,8,100,0.6391,,
Cysteine and methionine metabolism,21,75,0.6365,,
Carbon metabolism,30,44.12,0.6484,,
"C1-unit interconversion, eukaryotes",6,100,0.6627,,
Amphetamine addiction,18,50,0.6736,,
2-Oxocarboxylic acid metabolism,20,100,0.6721,,
Primary immunodeficiency,5,71.43,0.6857,,
HTLV-I infection,139,92.67,0.6938,,
Holo-TFIIH complex,10,100,0.7194,,
Ubiquitin mediated proteolysis,68,77.27,0.7319,,
Survival motor neuron (SMN) complex,8,100,0.728,,
Pyruvate metabolism,14,48.28,0.7555,,
APC/C complex,7,58.33,0.7768,,
Inositol phosphate metabolism,22,47.83,0.805,,
Metabolic pathways,516,89.12,0.8199,,
Cortisol synthesis and secretion,7,25,0.8384,,
Endometrial cancer,15,44.12,0.8418,,
Glycerolipid metabolism,16,64,0.865,,
beta-Alanine metabolism,19,100,0.8878,,
Methionine salvage pathway,5,100,0.8818,,
Huntington's disease,75,69.44,0.8856,,
Immunoproteasome,14,100,0.8798,,
Colorectal cancer,36,64.29,0.8789,,
"Gluconeogenesis, oxaloacetate => fructose-6P",8,100,0.8821,,
Glucagon signaling pathway,37,72.55,0.8783,,
Amyotrophic lateral sclerosis (ALS),20,64.52,0.8746,,
Central carbon metabolism in cancer,21,50,0.8754,,
Parkinson's disease,42,56,0.8786,,
"Alanine, aspartate and glutamate metabolism",13,56.52,0.8876,,
Fructose and mannose metabolism,5,27.78,0.902,,
Thyroid hormone signaling pathway,47,64.38,0.8977,,
Cytosolic DNA-sensing pathway,20,62.5,0.9016,,
Sulfur metabolism,5,55.56,0.8992,,
Metabolism of xenobiotics by cytochrome P450,8,30.77,0.8981,,
Chemical carcinogenesis - DNA adducts,7,35,0.8918,,
Methionine degradation,3,50,0.8942,,
Hepatitis C,60,73.17,0.9052,,
Signaling pathways regulating pluripotency of stem cells,59,74.68,0.9082,,
THC complex,5,100,0.9022,,
Fat digestion and absorption,12,100,0.9168,,
Gastric cancer,49,68.06,0.9105,,
Chronic myeloid leukemia,42,77.78,0.9148,,
Cytochrome c oxidase,14,100,0.9183,,
ATP-dependent chromatin remodeling,61,88.41,0.9358,,
Gap junction,27,58.7,0.9537,,
Huntington disease,121,75.16,0.9638,,
African trypanosomiasis,14,100,0.9715,,
Hepatocellular carcinoma,77,76.24,0.9644,,
Long-term potentiation,23,57.5,0.9738,,
"Aminoacyl-tRNA biosynthesis, eukaryotes",18,72,0.9835,,
Fluid shear stress and atherosclerosis,31,37.35,0.9912,,
Notch signaling pathway,19,57.58,0.9979,,
Prostate cancer,50,83.33,1,,
Biosynthesis of amino acids,21,50,0.998,,
ECS complex,7,100,1,,
Butanoate metabolism,11,100,1,,
Longevity regulating pathway - multiple species,13,33.33,0.9944,,
Melanoma,25,62.5,0.9938,,
Spinocerebellar ataxia,47,58.02,0.9896,,
Acute myeloid leukemia,28,70,0.9867,,
Herpes simplex virus 1 infection,133,88.08,0.9807,,
Aminoacyl-tRNA biosynthesis,22,75.86,0.9795,,
Basal cell carcinoma,24,100,0.9735,,
"Guanine ribonucleotide biosynthesis IMP => GDP,GTP",9,100,0.9722,,
Peroxisome,11,27.5,0.9677,,
Lipoic acid metabolism,11,100,0.9675,,
Endocrine resistance,37,63.79,0.9655,,
Histidine metabolism,11,100,0.9603,,
Proteasome,16,53.33,0.9603,,
Arrhythmogenic right ventricular cardiomyopathy,14,35.9,0.9596,,
Arrhythmogenic right ventricular cardiomyopathy (ARVC),14,36.84,0.9536,,
NOD-like receptor signaling pathway,44,46.32,0.9564,,
Non-small cell lung cancer,29,65.91,0.9512,,
Antigen processing and presentation,14,58.33,0.9656,,
Pentose phosphate pathway,13,100,0.9601,,
Oxytocin signaling pathway,34,49.28,0.9583,,
Glioma,23,50,0.9701,,
Arginine biosynthesis,9,100,0.9714,,
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex,11,100,0.9681,,
Viral carcinogenesis,108,88.52,0.9673,,
Necroptosis,43,56.58,0.9725,,
ESCRT-III complex,2,25,0.9739,,
Estrogen signaling pathway,42,65.62,0.9691,,
Toll-like receptor signaling,10,100,0.9667,,
ErbB signaling pathway,24,47.06,0.9663,,
Wnt signaling,13,100,0.9613,,
Leishmaniasis,10,31.25,0.9655,,
Arachidonic acid metabolism,7,30.43,0.9649,,
Lipid and atherosclerosis,61,61.62,0.977,,
Type II diabetes mellitus,18,100,0.987,,
Protein processing in endoplasmic reticulum,34,37.78,0.9955,,
Th17 cell differentiation,28,57.14,0.9945,,
Hippo signaling,1,8.33,NA,,
